Cash flow Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
After market 21:52:22 | |||
95.65 USD | +1.10% | 96.02 | +0.38% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.7B | -82M | 1.04B | 698M | 1.59B | |||||
Depreciation & Amortization - CF | 312M | 334M | 352M | 333M | 368M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 699M | 789M | 741M | 803M | 828M | |||||
Depreciation & Amortization, Total | 1.01B | 1.12B | 1.09B | 1.14B | 1.2B | |||||
(Gain) Loss From Sale Of Asset | -8M | - | -78M | 22M | - | |||||
(Gain) Loss on Sale of Investments - (CF) | 30M | -398M | -250M | 1M | 59M | |||||
Asset Writedown & Restructuring Costs | 105M | 533M | 370M | 132M | 58M | |||||
Stock-Based Compensation (CF) | 157M | 170M | 194M | 220M | 233M | |||||
Other Operating Activities, Total | -3.88B | 120M | -149M | 322M | 135M | |||||
Change In Accounts Receivable | -130M | 335M | -279M | -220M | -238M | |||||
Change In Inventories | -290M | -65M | -346M | -321M | -660M | |||||
Change In Accounts Payable | 111M | 88M | 408M | -255M | 118M | |||||
Change in Other Net Operating Assets | 27M | -316M | -134M | -209M | 10M | |||||
Cash from Operations | 1.84B | 1.51B | 1.87B | 1.53B | 2.5B | |||||
Capital Expenditure | -461M | -376M | -554M | -588M | -711M | |||||
Sale of Property, Plant, and Equipment | 7M | 12M | 14M | 12M | 4M | |||||
Cash Acquisitions | -4.38B | -3M | -2.26B | -1.54B | -1.81B | |||||
Divestitures | 90M | 15M | 826M | 5M | - | |||||
Sale (Purchase) of Intangible assets | 52M | 87M | 82M | 70M | 30M | |||||
Investment in Marketable and Equity Securities, Total | -149M | -146M | 279M | -24M | -89M | |||||
Other Investing Activities, Total | -198M | - | 14M | 56M | 3M | |||||
Cash from Investing | -5.04B | -411M | -1.6B | -2.01B | -2.57B | |||||
Short Term Debt Issued, Total | 700M | 4.16B | - | - | - | |||||
Long-Term Debt Issued, Total | 7.23B | 1.68B | - | 3.27B | - | |||||
Total Debt Issued | 7.93B | 5.84B | - | 3.27B | - | |||||
Short Term Debt Repaid, Total | -1.58B | -5.58B | - | -251M | -4M | |||||
Long-Term Debt Repaid, Total | -3.56B | -1.26B | - | -3.18B | - | |||||
Total Debt Repaid | -5.14B | -6.84B | - | -3.44B | -4M | |||||
Issuance of Common Stock | 123M | 1.09B | 110M | 136M | 182M | |||||
Repurchase of Common Stock | - | -535M | - | - | - | |||||
Issuance of Preferred Stock | - | 975M | - | - | - | |||||
Preferred Dividends Paid | - | -28M | -55M | -55M | -28M | |||||
Common & Preferred Stock Dividends Paid | - | -28M | -55M | -55M | -28M | |||||
Other Financing Activities, Total | 56M | -206M | -150M | -464M | -145M | |||||
Cash from Financing | 2.97B | 293M | -95M | -548M | 5M | |||||
Foreign Exchange Rate Adjustments | 10M | -2M | -6M | -9M | -4M | |||||
Miscellaneous Cash Flow Adjustments | - | - | 1M | - | - | |||||
Net Change in Cash | -222M | 1.39B | 173M | -1.04B | -70M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 449M | 359M | 338M | 450M | 259M | |||||
Cash Income Tax Paid (Refund) | 242M | 207M | 302M | 662M | 512M | |||||
Levered Free Cash Flow | 1.39B | 1.22B | 2.77B | 1.15B | 1.88B | |||||
Unlevered Free Cash Flow | 1.68B | 1.45B | 2.98B | 1.45B | 2.05B | |||||
Change In Net Working Capital | 206M | 263M | -912M | 660M | 213M | |||||
Net Debt Issued / Repaid | 2.79B | -999M | - | -165M | -4M |